Bisphosphonates may not protect women from breast cancer as had been thought, states new study. The drugs' protective effect was widely assumed after several observational studies showed that women who took them were less likely to get breast cancer. But when researchers assessed the effect of two of the most widely used osteoporosis drugs - sold under the brand names, Fosamax and Reclast - in two large randomized clinical trials, neither drug protected ...Tuesday 12 August 2014
Bone Drugs may Not Protect Osteoporotic Women from Breast Cancer: Study
Bisphosphonates may not protect women from breast cancer as had been thought, states new study. The drugs' protective effect was widely assumed after several observational studies showed that women who took them were less likely to get breast cancer. But when researchers assessed the effect of two of the most widely used osteoporosis drugs - sold under the brand names, Fosamax and Reclast - in two large randomized clinical trials, neither drug protected ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment